Created at Source Raw Value Validated value
March 10, 2021, 1 a.m. irct

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: Placebo (Nano Alvand daru) 1 oral tablet daily + Remdesivir IV 100 mg daily for 14 days or hospital discharge (whichever comes first)", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Tofacitinib10 mg (Rofanib, Nano Alvand ) 1 oral tablet daily + Remdesivir IV 100 mg daily for 14 days or hospital discharge (whichever comes first)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1300, "treatment_name": "Tofacitinib", "treatment_type": "Kinase inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]